Chief Medical Officer - Vascular

Compremium AG; Bern; Híbrido; CHF 300.000 - 600.000; Jornada completa

Ventajas ofrecidas por este puesto de trabajo

Global clinical leadership opportunity

Executive exposure to strategic payer

Mission-driven entrepreneurial team

Descripción de la vacante

Compremium AG, based in Bern, Switzerland, seeks an MD with board certification to serve as Chief Medical Officer. The role leads clinical strategy, medical affairs, regulatory alignment, and evidence generation for the Quantis CVP platform.

It involves collaboration with clinicians worldwide to redefine venous pressure measurement standards. The CMO will drive high‑visibility external initiatives, coordinate across functions, and shape payer engagement and adoption strategies while advancing

Formación

• Executive leader with clinical and scientific vision and strong execution capabilities.
• Experience communicating complex clinical data to diverse stakeholders.
• Collaborative leader able to drive cross-functional programs across geographies.
• Proven ability to influence clinicians, regulators, payers, and partners.

Responsabilidades

• Define and lead global clinical strategy for Quantis CVP across acute and chronic pathways.
• Translate unmet clinical needs into actionable product and evidence plans.
• Serve as medical authority and spokesperson to clinicians, hospitals, and regulatory bodies.
• Oversee clinical studies validating non-invasive CVP and develop performance claims.
• Lead Medical Affairs and engage global KOLs and Advisory Boards.
• Shape regulatory labeling and evidence requirements for FDA/CE submissions.
• Partner with HEOR to articulate value and reimbursement pathways.
• Support market access and clinical adoption through cross-functional collaboration.

Conocimientos

Executive leadership

Clinical strategy

Medical affairs

KOL engagement

Communication

Cross-functional collaboration

Educación

MD with board certification

Descripción del empleo

The Chief Medical Officer (CMO) for Venous Pressure Solutions will serve as the clinical, scientific, and strategic leader driving the validation, adoption, and scaling of the solution. This executive will oversee clinical positioning, medical affairs, evidence generation, KOL engagement, regulatory-medical alignment, and strategic payer-reimbursement positioning.

The CMO will work closely with leading clinicians worldwide to establish Quantis CVP as a new standard of care. The role is highly visible, externally facing, and will play a pivotal role in changing the clinical guidelines for venous pressure measurements.

• Visionary and strategic clinical thinker with strong execution skills.
• Exceptional scientific and clinical communicator, both written and verbal.
• Highly collaborative leader able to work effectively across functions and geographies.
• Strong influencing skills with clinicians, regulators, payers, and commercial partners.

Why join Compremium

• Opportunity to lead the clinical transformation of a groundbreaking diagnostic platform poised to redefine the standard of care.
• Join a mission-driven, entrepreneurial team advancing a category-defining, non-invasive diagnostic technology with global ambition.

1. Clinical Strategy & Leadership

• Define and lead the global clinical strategy for Quantis CVP across the various acute and chronic pathways.
• Translate core clinical unmet needs into actionable product and clinical evidence.
• Serve as the medical authority and spokesperson to clinicians, hospital systems, and regulatory bodies.

2. Clinical Evidence Generation

• Design and oversee clinical studies validating non-invasive CVP.
• Develop clinical performance claims aligned with FDA, CE-mark, and future pathways.
• Ensure evidence supports accuracy, utility, workflow impact, and health-economic value.
• Drive publications and conference presence.

3. Medical Affairs & KOL Engagement

• Build and lead the Medical Affairs function.
• Identify, recruit, and manage the exchanges with global KOLs, particularly by orchestrating Advisory Board meetings.
• Support physician education, onboarding, and clinical messaging.

4. Regulatory & Quality Alignment

• Shape clinical claims, labeling, and evidence requirements for FDA, CE and other regulatory submissions.
• Provide medical oversight for risk management and clinical safety.

5. Health Economics & Reimbursement Strategy

• Partner with HEOR experts to articulate the value of the solution for patients, clinicians, hospitals, and payers.
• Support development of reimbursement models, coding strategies, and payer engagement pathways.

6. Commercial & Market Development Support

• Partner with commercial teams to refine workflows, onboarding frameworks, and clinical adoption playbooks.
• Provide medical leadership during evaluations and customer interactions pertaining to clinical business development.
• Ensure alignment with product roadmap and market segmentation.

• MD with board certification and clinical experience in Emergency Medicine, Critical Care, Cardiology, Anesthesiology, internal medicine, or related field.
• Expertise in hemodynamics, venous congestion, shock, and fluid resuscitation or other related areas pertaining to venous pressure measurement.
• Established KOL and academic network within relevant specialties.
• Ability to travel within Europe and Internationally to attend conferences and hospital clients.
• Excellent command of English, with strong presentation and public speaking skills.

Required Knowledge, Skills, & Abilities

• Peer-reviewed publications in hemodynamics, CVP, heart failure, or shock.
• Prior MedTech industry experience.
• Leadership experience in clinical research or medical affairs.
• Experience with diagnostics or monitoring technologies such as ultrasound, AI-enabled tools, or other non-invasive solutions.
• Proven track record in implementing new clinical solutions in hospital environments.

About Compremium AG

Compremium is a medical diagnostics company based in Bern, Switzerland. We are on a mission to transform the diagnosis of pressure-related conditions in the human body with our first-of-its-kind, non-invasive platform technology. Our first product is cleared by the FDA and CE and is currently used by multiple reputed institutions in the United States and Europe. Our second product has recently been granted FDA breakthrough designation and is being used by NASA in the International Space Station. We are launching our products in the United States and Europe, with a rapid expansion plan to scale quickly.